Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: xcr600 who wrote (29663)	4/14/2006 12:16:33 PM
From: xcr600	Respond to of 48461

possible area for some future rats.. or a buying opp on some ETFs for the long term picture. ---------- Top U.S. scientists lured to Asia Lavish aid, state-of-the-art labs and high salaries are proving irresistible to some. Paul Elias, Associated Press CHICAGO - Singapore's siren song is growing increasingly irresistible for scientists, especially stem cell researchers who feel stifled by the U.S. government's restrictions on their field. Two prominent California scientists are the latest to defect to the Asian city-state, announcing earlier this month that they, too, had fallen for its glittering acres of new laboratories outfitted with the latest gizmos. They weren't the first defections, and Singapore officials at the Biotechnology Organization's annual convention in Chicago this week promise they won't be the last. Other Asian countries, including Japan, South Korea and even China, are also here touting their burgeoning biotechnology spending to the 20,000 scientists and biotech executives attending the conference. But what sets Singapore apart is the sheer size of its effort to become the "Boston of the east" -- along with its promise to limit government meddling. The 250-square-mile island nation known to some as the place that canes miscreants and has issues with chewing gum has already spent $4 billion on biotechnology and has committed another $8 billion through 2010 in a bid to give the United States a run for biomedical supremacy. "I am absolutely amazed at what they have. It's just knock-dead gorgeous," said Dr. Judith Swain, a University of California, San Diego, heart researcher who will decamp to Singapore in September to run the new Singapore Institute for Clinical Sciences at a state-funded research wonderland called Biopolis. Swain's husband, Dr. Edward Holmes, who is dean of the UCSD medical school and a ranking official with California's stem cell agency, is also going to Singapore to work as a government researcher. The two join Alan Colman, the British researcher who played a pivotal role in cloning Dolly the sheep; another husband-and-wife team, National Institutes of Health researchers Neal Copeland and Nancy Jenkins; and an increasing number of stem cell scientists. All have been lured by lucrative pay, state-of-the art labs and -- the clincher -- nearly unlimited government support. In all, about 50 senior scientists have been recruited -- far short of what it needs, but a start for a tiny country of 4.5 million people off the tip of Malaysia. Another 1,800 younger scientists from all corners of the world staff the Biopolis labs, which were built with $290 million in government funding and another $400 million in private investment. ©2006 Associated Press. All rights reserved.

To: xcr600 who wrote (29663)	4/17/2006 11:33:47 AM
From: Bucky Katt	Read Replies (1) \| Respond to of 48461

The dollar is getting pummeled.